Project Grant R03DK144241
- This federal Project Grant award of $737,949 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research to modernize clinical methods for assessing fluid excess and removal during in-center hemodialysis treatment. The long-term goal is to improve patient-centered outcomes by leveraging newer techniques like multi-frequency bioelectrical impedance spectroscopy...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Emory University a $818,481 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct a longitudinal study on the quality of everyday life experiences among home dialysis patients and their family caregivers. The 5-year study, which began in September 2025, aims to characterize the quality of life and understand how home dialysis patients and their...
- This federal Project Grant award of $193,984 from the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) supports research to investigate the interplay between inflammation, angiogenesis, myocardial perfusion, and myocardial function in patients with advanced chronic kidney disease (CKD). The project, conducted by Brigham & Women's Hospital Inc., aims to mechanistically explore cardiovascular health before and after kidney transplantation. Key objectives...
- The federal Project Grant award of $131,886 was provided by the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) to Brigham & Women's Hospital Inc., a subsidiary of Partners Healthcare System, to conduct research on the use of bioimpedance as a tool to assess volume status and predict cardiovascular outcomes in patients with chronic kidney disease. The study aims to 1) examine the predictive capacity of changes in volume measured by bioimpedance for...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), through its Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded a $350,000 Project Grant to Katharos, Inc. on Jun 20, 2025. The grant supports the development of a novel extracorporeal technology, the "Phosfilter" device, which aims to enhance phosphate removal from the blood of hemodialysis patients and reduce the incidence of high phosphate-associated morbidity and...
- This federal Project Grant award, totaling $813,284.00 and provided by the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research), supports a research study on the relationship between acute kidney injury (AKI) and delirium in patients who have undergone cardiac surgery. The key objectives of this 5-year study are to: 1) determine the incidence and clinical characteristics of AKI-associated delirium in cardiac surgery patients, 2) delineate the signaling...
- This Project Grant award, valued at $199,130.00, was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The objective is to demonstrate the clinical utility of patient-reported outcome measures (PROMs) in the care of individuals with advanced chronic kidney disease (CKD). The award will fund research across two key areas: 1) developing and validating risk...
- This $810,330 Project Grant was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research (CFDA 93.847) program, to The Regents of the University of California, San Francisco (UCSF). The grant aims to leverage electronic health record data to understand how provider communication about kidney replacement therapy (KRT) options, such as home dialysis and kidney transplantation, may vary across...
- This Project Grant award of $314,279 from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) supports the development and evaluation of an innovative dialysis cannulation needle. The proposed product aims to reduce accidental needle infiltration injuries and improve the safety and efficacy of home and in-center renal dialysis therapy. The award was made to Minnesota Healthsolutions Corporation, a...
- This federal Project Grant award, valued at $209,832.00 and provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under CFDA 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research, will support research at New York University (NYU) to improve the understanding of the role of the autonomic nervous system (ANS) in the cardiovascular complications of chronic kidney disease (CKD). The 5-year project aims to develop the candidate's skills in ANS...
This $268,500 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research program) will support the "Incident Hemodialysis Electrolyte Analysis and Rhythm Trends (IHEART)" study conducted by Dr. Katherine Ravi at Brigham & Women's Hospital. The study aims to investigate how cardiac rhythm morphology associated with sudden cardiac death evolves during the early stages of hemodialysis and how serum electrolyte levels are associated with these changes. The 2-year project will recruit 33 patients initiating hemodialysis to perform a cohort study analyzing QTc duration, ventricular ectopy, and heart rate variability trends in relation to serum electrolyte levels. This research is intended to improve understanding of cardiac risks during the vulnerable period of hemodialysis initiation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $268.5k | 9/8/25 |